Biosolution Co.Ltd (086820) — Cash Flow-to-Debt Ratio
Biosolution Co.Ltd (086820) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of ₩17.41 Million could theoretically repay 0% of its total liabilities (₩36.25 Billion) in one year. See 086820 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biosolution Co.Ltd Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Biosolution Co.Ltd across 10 annual periods. For the full cash flow conversion analysis, see 086820 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Biosolution Co.Ltd (2015–2024)
Year-by-year debt coverage analysis for Biosolution Co.Ltd. Check how high is Biosolution Co.Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.06x | ₩-2.29 Billion | ₩36.21 Billion | ▼ -246.8% |
| 2023 | 0.04x | ₩2.16 Billion | ₩50.22 Billion | ▲ +154.1% |
| 2022 | -0.08x | ₩-3.81 Billion | ₩47.96 Billion | ▼ -4815.9% |
| 2021 | 0.00x | ₩83.29 Million | ₩49.39 Billion | ▲ +100.3% |
| 2020 | -0.54x | ₩-1.69 Billion | ₩3.13 Billion | ▲ +23.4% |
| 2019 | -0.70x | ₩-2.61 Billion | ₩3.71 Billion | ▼ -360.2% |
| 2018 | 0.27x | ₩1.03 Billion | ₩3.80 Billion | ▲ +1117.6% |
| 2017 | -0.03x | ₩-78.53 Million | ₩2.96 Billion | ▲ +96.5% |
| 2016 | -0.77x | ₩-2.07 Billion | ₩2.70 Billion | ▲ +8.8% |
| 2015 | -0.84x | ₩-2.02 Billion | ₩2.40 Billion | — |